|
|
13 Aug 2002
De Beers decided to provide the drugs following its heavy criticism of the South African government's handling of the pandemic, which is believed to have infected nearly five million people in the country, according to reports.
It also comes after the South African Institute of Chartered Accountants called on companies to include the cost of the disease in their financial reports, and is spearheading a campaign to make it a compulsory listings requirement on the Johannesburg Stock Exchange.
It is estimated that 12% of De Beer's 11,000 South African employees have HIV/AIDS. The company will pay 90% of the cost of the treatment, around £1,600, with employees expected to pay the remaining 10%.
Earlier this month Anglo American, which owns a 45% stake in De Beers, announced plans to provide its workforce with HIV/AIDS drugs free of charge.
You may also like
Search thousands of financial jobs:
Search thousands of financial jobs:
Careers
Search for jobs
Click to search our database of all the latest accountancy roles
Create a profile
Click to set up your profile and let the best recruiters find you
Jobs by email
Sign up to receive regular updates with the latest roles suitable for you
Briefings
By looking at the reasons supplier statements became unfashionable, and the reasons why it is different today, this paper delves into the many benefits that can be obtained by automating the process.
Having a real and true view of your organisation’s current financial position, and having the right systems and processes in place, will ensure that you can make strong choices and are ready to capitalise on opportunities
AccountancyAgeInsight is a frequently updated resource centre for finance professionals, offering a free and easy-to-use digital library of briefings, white papers and other information resources. 
Visitor comments Add your comment